Friday, 21 August 2020

Gilead remdesivir study finds only marginal benefit for moderate Covid-19 patients



from The Indian Express https://ift.tt/34lU7WI
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)